CenExel CEO Ryan Brooks Moderates Executive Panel at Alloy Healthcare Forum in New York City

May 13, 2025 9:00 AM

CenExel, a leading clinical trial site network, proudly announces that its Chief Executive Officer, Ryan Brooks, participated in the Alloy Healthcare Executive Forum held in New York City on Tuesday, May 6, 2025. Hosted by Alloy Partners, a venture builder dedicated to creating advantaged startups in collaboration with leading corporations, the forum brought together top minds from across the healthcare and life sciences industries.Ryan...

Read more

Rudy Novak, Vice President of Clinical Partnerships at the Ridge RTC, Named to the Frontline Honors Class of 2024 by WTWH Healthcare

May 13, 2025 9:00 AM

The Ridge RTC, an established provider of residential mental health services for adolescents, is thrilled to announce that Rudy Novak, Vice President of Clinical Partnerships at Ridge RTC, has been recognized as part of WTWH Healthcare's Frontline Honors Class of 2024. The much-deserved honor celebrates Novak's commitment to advancing effective mental health treatment for America's youth through strategic clinical partnerships that help improve...

Read more

The 2024 Responsible Business and Impact Report Shares How Gilead Sciences Is Driving Change

May 13, 2025 8:50 AM

At Gilead, we innovate for impact. This commitment helps us drive scientific solutions forward, reach more people in more places and protect the planet we all share. Read our 2024 Responsible Business and Impact Report to see how we're driving change and working toward our vision to create a healthier world for all people. https://www.gilead.com/company/annual-impact-reportsGilead SciencesGilead Sciences, Inc. is a research-based...

Read more

REMSleep Enters Formal Agreement with Major Distributor

May 13, 2025 8:23 AM

REMSleep Holdings, Inc. (OTC PINK:RMSL) Enters into Formal Agreement with www.1800CPAP.com , a major DME distributor. The DeltaWave is now available nationwide.Tom Wood, CEO " We are happy to announce our marketing and distribution agreement with www.1800cpap.com The new Deltawave is now featured as "New Arrival" CPAP Nasal Pillow on the website https://www.1800cpap.com/deltawave-cpap-mask-system. 1800 CPAP has a strong advertising and outreach...

Read more

CNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287

May 13, 2025 7:00 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced the successful transfer from Cortice Biosciences, Inc. of Orphan Drug Designation for TPI 287. The U.S. Food and Drug Administration (FDA) previously granted Orphan Drug Designations for TPI 287 in treating...

Read more

Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy

May 13, 2025 6:30 AM

ANN ARBOR, MI / ACCESS Newswire / May 13, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the launch of the Equine Asthma Clinical Registry. This pioneering program leverages PulseVet® shock wave therapy to offer a non-invasive, drug-free treatment alternative for horses suffering from...

Read more

BioNxt Reports Expanded Research, Development and Commercialization Capability with Centralized Munich Laboratory

May 13, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, is pleased to announce the integration of its research, development and commercialization activities to the Gen-Plus GmbH & Co. KG (Gen-Plus) Contract Research and Development Organization (CRDO) in Munich, Germany. The move provides BioNxt with enhanced R&D capabilities, collaboration...

Read more

Cantargia Publishes Interim Report for the First Quarter of 2025

May 13, 2025 1:20 AM

Cantargia (STO:CANTA) - Cantargia (Cantargia AB (publ); Nasdaq Stockholm: CANTA) today announced its interim report for the first quarter of 2025."The first quarter of 2025 has been rich in positive news for Cantargia. We continue to progress on all fronts, with strong news flow on all our projects and ongoing discussions regarding potential transactions that can be transformative for Cantargia. However, this has unfortunately been against a...

Read more

IRLAB is Granted a Patent Expanding the Patent Protection for the Drug Candidate Mesdopetam in the US

May 13, 2025 1:20 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 13, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company has been granted an additional ‘composition of matter patent' in the US covering the salt of mesdopetam intended for use in the forthcoming pharmaceutical product and the process of its manufacture. The now...

Read more

The Inheritance Nobody Wants: How Alzheimer's Steals Futures Before It Claims Memories

May 12, 2025 8:30 PM

As the number of families affected by Alzheimer's disease continues to grow, so does the financial and emotional strain on caregivers. In response, the Alzheimer's Family of Friends Foundation (AFOF) has announced a bold $2 million fundraising campaign for 2025 to expand its suite of direct-relief services-including financial aid programs and caregiver support groups that serve as lifelines for struggling households.Founded with a mission...

Read more

From Inside Out: Hollywood's Own Victoria Summer Unveils the Future of Anti-Aging With Beauty-Stem's Latest Innovations

May 12, 2025 6:50 PM

On April 19, 2025, Beauty-Stem hosted its annual gala in Southern California, bringing together philanthropists, celebrities, and leaders from the medical and wellness industries. The evening spotlighted the U.S. debut of the Miracle-48™ Revitalization Series, an innovation combining skincare and regenerative science.Victoria Summer's Testimony and PerformanceInternational superstar Victoria Summer lit up the stage with a captivating live...

Read more

Miracle-48 Launches in the U.S., Bringing Regenerative Skincare to the Forefront

May 12, 2025 6:30 PM

Beauty-Stem Biomedical, a biotech-driven beauty and wellness company, officially unveiled its flagship product Miracle-48™ at a high-profile brand event held in Southern California. Attended by leaders from the business, medical, and philanthropic sectors, the evening marked a significant milestone for the brand's U.S. expansion and showcased its latest innovation in skin rejuvenation.A Science-Based Breakthrough Years in the MakingDeveloped by...

Read more

On International Nurses Day, a New State of the World’s Nursing Report Charts a Path Toward Universal Health Coverage

May 12, 2025 4:00 PM

As the world's nurses celebrate International Nurses Day (IND), ICN issues a rallying cry to governments around the globe for urgent nursing support, following the launch of the second World Health Organization (WHO) State of the World's Nursing (SOWN) report.The SOWN report is a vital assessment of the global nursing workforce in the aftermath of the COVID-19 pandemic and underscores the urgent need for bold investments in nursing to address...

Read more

AmeriPro Health Names Adam Koontz as Chief Operating Officer

May 12, 2025 2:00 PM

AmeriPro Health, an industry leader in emergency services, patient logistics, and technology-driven healthcare services and solutions, announced today the hiring of Adam Koontz as the company's new chief operating officer. In this role, Koontz will lead operational strategy and execution across the organization, focusing on driving efficiency, aligning resources, and enhancing service delivery.With two decades of executive leadership experience...

Read more

Ovaterra Supplements Contain Complete Ingredients for Reproductive and Prenatal Health

May 12, 2025 11:15 AM

Ovaterra, a New York City-based fertility nutraceutical company, is helping meet the reproductive health needs of women with two unique supplements designed specifically for the support of reproductive and prenatal health.Fertinatal® DHEA and Advanced Prenatal contain key ingredients in amounts consistent with those studied for their potential to support conception and a healthy pregnancy. Both supplements are intended to give maximum...

Read more

EDGe Surgical Appoints Leo Carayannopoulos as Chief Executive Officer

May 12, 2025 10:00 AM

EDGe Surgical, a medical device company transforming orthopedic and spine surgery through single-use digital instruments, today announced the appointment of Leo Carayannopoulos as Chief Executive Officer.Carayannopoulos brings a strong track record of leadership in the medtech industry, with extensive experience in commercial strategy, product development, and scaling high-growth healthcare ventures. His appointment follows EDGe Surgical's...

Read more

UK, Ireland, Germany, India, France, Saudi Arabia, and Brazil Reshape the Global EHR Landscape in 2025 - Black Book Study Update

May 12, 2025 10:00 AM

Black Book™ Research today released a detailed country-level supplement to the Q2 2025 Global Healthcare IT Report, spotlighting the complex landscape of electronic health record (EHR) adoption across the world. Drawing on responses from 11,054 healthcare IT executives, clinicians, and decision-makers across 44 countries during Q1 2025, the new findings emphasize the dramatic differences in EHR progress and setbacks across seven key...

Read more

Genomate Health Brings European Innovation and $2M in Investment to the United States

May 12, 2025 8:45 AM

Genomate Health was founded in 2022 as a spin-out of Oncompass Medicine, a Hungarian medical technology company. The company brings to market a new category of computational tools for Digital Drug Assignment (DDA) - a breakthrough method that uses advanced computational reasoning to match the most effective, personalized drug treatment to each patient's unique biological and clinical profile.The expansion into the United States marks a pivotal...

Read more

Secarna Pharmaceuticals and Curie.Bio Portfolio Company Enter into Research and Option Agreement

May 12, 2025 8:10 AM

Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of best-in-class oligonucleotide therapeutics, today announced the signing of a research and option agreement for a scientific and strategic collaboration with one of Curie.Bio's portfolio companies.Under the agreement, Secarna will leverage its commercially validated OligoCreator® platform to design and develop oligonucleotide candidates against an...

Read more

Ensysce Biosciences Bolsters Management Team with Regulatory Expert

May 12, 2025 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for abuse and overdose, today announced it has added Tracy Hysong, CCRA as Senior Director of Regulatory Affairs to its management team.Ms. Hysong is a Certified Clinical Research Associate (CCRA) through the Association of Clinical Research Professionals...

Read more